Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Top Stocks To Watch Today: CPXX, FEYE, FPRX, GWPH

Published 04/07/2016, 12:54 AM
Updated 04/25/2018, 04:40 AM

It was a spectacular day on Wall Street on Wednesday. The market opened firm and moved up all session, closing at the highs for the day going away. We had a lot of stocks that moved very nicely. It was a great day for trading at TheTechTrader.com. Let’s take a look at some of those stocks.

Celator Pharm (NASDAQ:CPXX), one of our swing trades, is doing spectacular, up 65 cents to 13.08, or 5.2%, on 3.4 million shares. It popped, pulled back for two days, popped, pulled back for three days, and now it’s moving again. The top of the channel says this stock could be 17-18 short-term, especially if it takes out the 12.70-75 range as early as Thursday.

Fireeye Inc (NASDAQ:FEYE) has come down from the high 50’s to the low teens, reversed, and is now coiling above the moving averages. A swing was put on it in anticipation of this move. The first target is 19 1/2, and the secondary target is 22 1/2. We will see where this stock wants to go from there. On Wednesday it was up 75 cents to 38.71, or 4.3%, on 4 million shares.

Five Prm Th (NASDAQ:FPRX), one of our swing trades, tagged its target today, up 3.01 to 45.80, or 7%, on 1.5 million shares. It’s been acting great since the inverse head-and-shoulder breakout. Look for a target of 50-51 short-term. It has 4.65 days to cover.

GW Pharmaceuticals Plc (NASDAQ:GWPH) is doing great, up 4.82 to 79.25, or 6.5%, on 680,700 shares traded. After the spectacular, explosive move it made recently, and then the pullback, pop, pullback that formed a double bottom, a swing was put on it on Wednesday, and it moved up a couple points. It looks like it will test the 91-92 zone, and if it breaks through, we could see upwards of 105-110.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks on the long side included ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), Advaxis Inc (NASDAQ:ADXS), Anacor Pharmaceuticals Inc (NASDAQ:ANAC), ANI Pharmaceuticals Inc (NASDAQ:ANIP), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Direxion Daily S&P Biotech Bull 3X Shares (NYSE:LABU), Lsb Industries Inc (NYSE:LXU), Celator Pharm (NASDAQ:CPXX), Fireeye Inc (NASDAQ:FEYE), Five Prm Th (NASDAQ:FPRX), GW Pharmaceuticals Plc (NASDAQ:GWPH), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Incyte Corporation (NASDAQ:INCY), Inogen Inc (NASDAQ:INGN), Inovio Pharmaceuticals Inc (NASDAQ:INO), Intracellular Th (NASDAQ:ITCI), Juno Therapeutic (NASDAQ:JUNO), Ocular Therapeutix Inc (NASDAQ:OCUL), Rackspace Hosting Inc (NYSE:RAX), Sorrento Therape (NASDAQ:SRNE), Sarepta Therapeutics Inc (NASDAQ:SRPT), Transenterix Inc (NYSE:TRXC), USA Technologies Inc (NASDAQ:USAT), Valeant Pharmaceuticals (NYSE:VRX) Valeant Pharmaceuticals International Inc (NYSE:VRX), and Weibo Corp (NASDAQ:WB).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.